SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: William who wrote (7848)11/25/1998 11:41:00 PM
From: Robert K.  Read Replies (2) | Respond to of 17367
 
As I "anticipate" a "possible" ,"response" from Robert S> regarding
the "potential" of bpi's "limited" abilities vs sepsis, I thought I would add to Georges post a bit.
There have recently been several patents on bpi and lbp (both xoma and non-xoma) recently.They do underscore the seeming increasing nature of the worldwide research into bpi family compounds. Patents afford protection.
At this juncture, I remain satisfied.
All IMo. All disclaimers always apply.